FDA Criticizes Quality Control At Wockhardt's US Unit
U.S. Food and Drug Administration officials on Friday criticized quality control and drug testing practices at a U.S. facility of Wockhardt Ltd., the Mumbai-based drugmaker that has already been hit with...To view the full article, register now.
Already a subscriber? Click here to view full article